about
Impact of menopause and diabetes on atherogenic lipid profile: is it worth to analyse lipoprotein subfractions to assess cardiovascular risk in women?The effects of treatment on lipoprotein subfractions evaluated by polyacrylamide gel electrophoresis in patients with autoimmune hypothyroidism and hyperthyroidismThe effect of insulin resistance and obesity on low-density lipoprotein particle size in childrenLow-density-lipoprotein particle size predicts a poor outcome in patients with atherothrombotic stroke.Observational study of lipid profile and LDL particle size in patients with metabolic syndrome.Smaller Mean LDL Particle Size and Higher Proportion of Small Dense LDL in Korean Type 2 Diabetic Patients.Exchanging carbohydrate or protein for fat improves lipid-related cardiovascular risk profile in overweight men and women when consumed ad libitum.Estimation of plasma apolipoprotein B concentration using routinely measured lipid biochemical tests in apparently healthy Asian adultsLow-density lipoprotein size and cardiovascular risk assessment.Deficient serum 25-hydroxyvitamin D is associated with an atherogenic lipid profile: The Very Large Database of Lipids (VLDL-3) studyClinical importance and therapeutic modulation of small dense low-density lipoprotein particles.Hepatitis C virus G1b infection decreases the number of small low-density lipoprotein particlesEffects of chitosan on plasma lipids and lipoproteins: a 4-month prospective pilot study.Update on the role of the atherogenic lipoprotein phenotype in cardiovascular prevention.Usefulness of the LDL-C/apoB ratio in the overall evaluation of atherogenicity of lipid profile.Lipid subclasses profiles and oxidative stress in aggressive periodontitis before and after treatment.Relative importance of different lipid risk factors for the development of myocardial infarction at a very young age (≤ 40 years of age).Elevation of small, dense low density lipoprotein cholesterol-a possible antecedent of atherogenic lipoprotein phenotype in type 2 diabetes patients in Jos, North-Central Nigeria.Effects of 12-week supplementation of Citrus bergamia extracts-based formulation CitriCholess on cholesterol and body weight in older adults with dyslipidemia: a randomized, double-blind, placebo-controlled trial.
P2860
Q30234825-2FA439EA-8C44-4A13-BAF2-AB61F3FB3C30Q34410638-108429C5-D71C-4F64-9867-76338CF31EEDQ34423197-6F5480F7-3D6E-41B6-B0B4-0749CA829CD6Q34996557-91D02F98-1736-455C-9376-664A5A445AFAQ35338399-2A3D77C2-FAC8-431E-8A22-006FEDD7E767Q35564087-E16A3FD7-C476-40B2-9515-5DB48AC86558Q36077835-12E2DFB7-B1AA-4714-960F-160A26BD8B71Q36281471-E2D91D5E-2ACC-4D10-9442-6CA26093C5E7Q36349994-E74A53AC-26C3-449F-BD4E-1D49C46783B1Q36603198-070AFB38-86BD-43BF-BB86-946CD649C2D8Q36675450-73F25D9A-DBF5-4A68-9002-A8D13CC9ECFBQ37146195-DDDAD727-3B23-4A16-84BB-021424AAAAF7Q39399592-C8CD0963-2990-4367-8703-64BAE1DD75A5Q40179094-D5F80AFB-63B2-406F-8DB8-371B19AF7D1DQ40680512-1B941186-79E4-4111-B498-F8F82C1F86C5Q40918418-489231DF-DEAA-43D5-A543-326A632F4823Q45046990-A8F33F3A-CF1C-492E-A9E3-B77B7CDD53EBQ47109492-BDA14423-0C19-4FE8-95D2-26BD3DA14F1DQ47113613-54BEECD2-644F-47EF-B506-E99413150272
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Should we measure routinely the LDL peak particle size?
@en
Should we measure routinely the LDL peak particle size?
@nl
type
label
Should we measure routinely the LDL peak particle size?
@en
Should we measure routinely the LDL peak particle size?
@nl
prefLabel
Should we measure routinely the LDL peak particle size?
@en
Should we measure routinely the LDL peak particle size?
@nl
P1476
Should we measure routinely the LDL peak particle size?
@en
P2093
Kaspar Berneis
P304
P356
10.1016/J.IJCARD.2005.02.035
P407
P577
2006-02-01T00:00:00Z